Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve

J Assist Reprod Genet. 2008 Nov-Dec;25(11-12):515-21. doi: 10.1007/s10815-008-9266-6. Epub 2008 Oct 30.

Abstract

Purpose: This retrospective study was carried out to evaluate whether increasing the starting dose of FSH stimulation above the standard dose of 150 IU/day in patients with low predicted ovarian reserve can improve IVF outcomes.

Method: A total of 122 women aged less than 36 years in their first cycle of IVF were identified as having likely low ovarian reserve based on a serum AMH measurement below 14 pmol/l. Thirty five women were administered the standard dose of 150 IU/day FSH, while the remaining 87 received a higher starting dose (200-300 IU/day FSH). There were no significant differences in age, BMI, antral follicle count, serum AMH, FSH or aetiology of infertility between the two dose groups.

Results: No significant improvement in oocyte and embryo yield or pregnancy rates was observed following an upward adjustment of FSH starting dose. While increasing the dose of FSH above 150 IU/day did not produce any adverse events such as OHSS, it did consume an extra 1,100 IU of FSH per IVF cycle.

Conclusion: The upward FSH dose adjustment in anticipation of low ovarian reserve can not be advocated as it is both expensive and of no proven clinical value.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Mullerian Hormone / blood*
  • Dose-Response Relationship, Drug
  • Female
  • Fertilization in Vitro / methods*
  • Follicle Stimulating Hormone / administration & dosage*
  • Humans
  • Male
  • Ovulation Induction / methods*
  • Ovulation Induction / standards
  • Pregnancy
  • Retrospective Studies

Substances

  • Anti-Mullerian Hormone
  • Follicle Stimulating Hormone